Prevalence of Hepatitis B Vaccination Coverage Versus Serologic Evidence of Hepatitis B Immunity in Children and Adolescents in the United States, 1999-2016

被引：0
|
作者：
Le, Michael [1 ]
Yeo, Yee Hui [1 ]
So, Samuel K. [2 ,3 ]
Gane, Edward J. [4 ]
Cheung, Ramsey [1 ,5 ]
Nguyen, Mindie H. [1 ]
机构：
[1] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Asian Liver Ctr, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA
[4] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand
[5] Vet Affairs Palo Alto Hlth Care, Div Gastroenterol & Hepatol, Palo Alto, CA USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2092
引用
收藏
页码：1192A / 1193A
页数：2
相关论文
共 50 条
  • [41] Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination
    Elrashidy, Heba
    El-Didamony, Gamal
    Elbahrawy, Ashraf
    Hashim, Alaa
    Alashker, Ahmed
    Morsy, Mohamed Hanafy
    Elwassief, Ahmed
    Elmestikawy, Amr
    Abdallah, Abdallah Mahmoud
    Mohammad, Abdel-Gawad Saeid
    Mostafa, Mohamed
    George, Nilly M.
    Abdelhafeez, Hafez
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (08) : 2336 - 2341
  • [42] Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007
    Ladak, F.
    Gjelsvik, A.
    Feller, E.
    Rosenthal, S.
    Montague, B. T.
    INFECTION, 2012, 40 (04) : 405 - 413
  • [43] Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007
    F. Ladak
    A. Gjelsvik
    E. Feller
    S. Rosenthal
    B. T. Montague
    Infection, 2012, 40 : 405 - 413
  • [44] HEPATITIS-B VACCINATION IN CHILDREN - PERSISTENCE OF IMMUNITY AT 9 YEARS
    MILNE, A
    HOPKIRK, N
    MOYES, CD
    JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (02) : 113 - 114
  • [45] Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection
    Koepke, Ruth
    Sill, Danielle N.
    Akhtar, Wajiha Z.
    Mitchell, Kailynn P.
    Guilfoyle, Sheila M.
    Westergaard, Ryan P.
    Schauer, Stephanie L.
    Vergeront, James M.
    PUBLIC HEALTH REPORTS, 2019, 134 (06) : 651 - 659
  • [46] Erratum to: Hepatitis B in the United States: ongoing missed opportunities for hepatitis B vaccination, evidence from the Behavioral Risk Factor Surveillance Survey, 2007
    F. Ladak
    A. Gjelsvik
    E. Feller
    S. R. Rosenthal
    B. T. Montague
    Infection, 2012, 40 (3) : 355 - 355
  • [47] Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination
    Ni, YH
    Chang, MH
    Huang, LM
    Chen, HL
    Hsu, HY
    Chiu, TY
    Tsai, KS
    Chen, DS
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (09) : 796 - 800
  • [48] An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China
    Guo Yonghao
    Xu Jin
    Li Jun
    Dong Pumei
    Ye Ying
    Feng Xiuhong
    Zhang Yanyang
    Guo Wanshen
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 40 : 75 - 80
  • [49] Hepatitis B Vaccination Coverage and Documented Seroprotection among Matriculating Healthcare Students at an Academic Institution in the United States
    Tohme, Rania A.
    Ribner, Bruce
    Huey, Michael J.
    Spradling, Philip R.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2011, 32 (08): : 818 - 821
  • [50] Knowledge, attitudes, practices and prevalence of hepatitis B and C and hepatitis B vaccination coverage among public sector healthcare workers in Cambodia
    By, Youlet
    Le, Linh-Vi
    Suy, Sovanthida
    Chou, Monidarin
    Chan, Po-lin
    Heng, Kanika
    Phou, Socheata
    Ny, Chanthou
    Deng, Serongkea
    Phoeung, Chan Leakhena
    Mam, Sovatha
    Ferradini, Laurent
    Babin, Francois-Xavier
    Saphonn, Vonthanak
    GLOBAL HEALTH & MEDICINE, 2024, 6 (02): : 108 - 116
12345